CVS Health Corporation (CVS)
Overview
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Explore More Data
Key Information
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Capital Structure (Updated: Nov 05 04:00 PM EST)
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-10-29 |
| Earnings Call | 2025-10-29 |
| Avg EPS Estimate | 0.9619 |
| Low EPS Estimate | 0.89 |
| High EPS Estimate | 1.23 |
| Revenue | |
| Avg Revenue Forecast | 102,288,379,450 |
| Low Revenue Forecast | 101,312,000,000 |
| High Revenue Forecast | 103,888,233,340 |
CVS Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $11,232,000,000 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 0.594 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 0.832 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $81,751,998,464 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
CVS Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $14,533,000,192 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $9,109,000,192 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $6,839,124,992 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 13.35% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 1.95% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | 0.12% | Net profit margin, which reflects overall profitability. |
CVS Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 111.82% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $81,751,998,464 | Used together with cash and EBITDA to assess debt-paying ability. |
CVS Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | 7.80% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 0.00% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for CVS (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $78.55 | Latest stock trading price |
| Price Target (High) | $103 | Analyst highest expected price |
| Price Target (Low) | $77 | Analyst lowest expected price |
| Price Target (Average) | $91.52 | Average target price across analysts |
| Price Target (Median) | $93 | Median of target prices |
| Average Rating Score | 1.57 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | buy | Consensus rating |
| Analyst Coverage Count | 25 | Number of analysts providing estimates |
| Cash Holdings | $11,232,000,000 | Total cash held by the company |
| Cash per Share | $8.85 | Cash value per outstanding share |
| Total Debt | $81,751,998,464 | Company's total debt |
| Quick Ratio | 0.594 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 0.832 | Overall short-term liquidity |
| Debt/Equity Ratio | 111.82% | Leverage ratio: Debt / Equity |
| EBITDA | $14,533,000,192 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $391,689,994,240 | Total company revenue |
| Revenue per Share | $309.636 | Total revenue divided by shares outstanding |
| Gross Profit | 13.35% | Revenue minus cost of goods sold |
| Return on Assets | 2.44% | Net income / Total assets |
| Return on Equity | 0.58% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 0.00% | Year-over-year EPS growth |
| Revenue Growth (YoY) | 7.80% | Year-over-year revenue growth |
| Gross Margin | 13.35% | Gross profit / Total revenue |
| EBITDA Margin | 3.71% | EBITDA / Revenue |
| Operating Margin | 1.95% | Operating income / Revenue |
| Profit Margin | 0.12% | Net income / Revenue |
| Free Cash Flow | $6,839,124,992 | Cash left after capital expenditures |
| Operating Cash Flow | $9,109,000,192 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |